https://www.straitstimes.com/tech/ai-to-act-as-doctor-s-second-pair-of-eyes-to-s pot-nearly-invisible-colon-cancer-growths Developed with the help of biomedical company Medtronic, the tool is able to detect roughly 20^ more growths—or polyps—that doctors would otherwise miss with the human eye, according to studies by SKH. Endoscope image processing by AI to discern near invisible (to the naked eye) polyps during a gastroscopy. FDA's TPLC platform identifies, to date, 4 separate devices under Product Code QNP (gastrointestinal lesion software detection system). See https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfTPLC/tplc.cfm?id=2260&min_report_year=2018 for device approval information. The polyp detector stack is defined as, “A gastrointestinal lesion software detection system is a computer-assisted detection device used in conjunction with endoscopy for the detection of abnormal lesions in the gastrointestinal tract. This device with advanced software algorithms brings attention to images to aid in the detection of lesions. The device may contain hardware to support interfacing with an endoscope.'' No medical device reports for device or patient problems. Stay tuned to this space. Among the many procedural risks (e.g., an unsterilized endoscope) for gastroscopy is perforation—the endoscope, via the gastroenterologist, pokes a hole through your intestine. Need to wonder if the polyp detector false negative/positive outcome might advise over-aggressive polyp biopsy frequency that elevates perforation risk.